Infectious Vaccines Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Type, By Product, By Country, & By Region

  • Report Id: HCDHR 2389
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Infectious Vaccines Market Report Overview

Infectious vaccines market garnered a revenue of USD xx million in the year 2019 globally and has been foreseen to grow at a compound annual growth (CAGR) of 13.4% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Infectious Vaccines market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Infectious Vaccines Total Available Market (TAM) Size
  • Infectious Vaccines Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights:

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Infectious Vaccines Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Infectious Vaccines Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Infectious Vaccines Market: Type Insights
4.1. Global Type Historic Market Data & Future Forecasts, 2016-2027
4.2. Inactivated
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Subunit
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Conjugate
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Attenuated
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Infectious Vaccines Market: Product Insights
5.1. Global Product Historic Market Data & Future Forecasts, 2016-2027
5.2. Therapeutic vaccine
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Preventive vaccine
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Others
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Infectious Vaccines Market: Regional Insights
6.1. Global Infectious Vaccines Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Type, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Product, 2016-2027
Chapter 7. Company Profiles
7.1. Pfizer Inc.
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Sanofi Pasteur
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Merck and Company
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Novartis AG
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Johnson and Johnson
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. MedImmune LLC
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Emergent Bio Solutions Inc.
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. GlaxoSmithKline plc.
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. CSL Limited
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. Bavarian Nordic
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives  
List of Tables
Table 1 Infectious Vaccines Market Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Infectious Vaccines Market Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 4 Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 7 Inactivated Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 Subunit Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 Conjugate Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 Attenuated Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 Others Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 13 Therapeutic vaccine Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 14 Preventive vaccine Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 Others Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 16 ] Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 17 North America Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 North America Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 19 North America Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 20 U.S. Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 21 U.S. Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 22 U.S. Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 23 Canada Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 24 Canada Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 25 Canada Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 26 Europe Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 27 Europe Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 28 Europe Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 29 U.K. Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 30 U.K Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 31 U.K Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 32 Germany Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 33 Germany Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 34 Germany Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 35 France Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 36 France Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 37 France Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 38 Asia Pacific Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 39 Asia Pacific Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 40 Asia Pacific Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 40 China Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 42 China Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 43 China Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 44 India Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 45 India Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 46 India Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 47 Japan Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 48 Japan Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 49 Japan Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 50 South Korea Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 51 South Korea Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 52 South Korea Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 53 Latin America Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 54 Latin America Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 55 Latin America Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 56 Brazil Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 57 Brazil Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 58 Brazil Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 59 Mexico Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 60 Mexico Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 61 Mexico Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 62 Middle East & Africa Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 63 Middle East & Africa Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 64 Middle East & Africa Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 65 UAE Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 66 UAE Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 67 UAE Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
Table 68 South Africa Infectious Vaccines Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 69 South Africa Infectious Vaccines Market Data & Future Forecasts, By Type, 2016-2027 (USD Million)
Table 70 South Africa Infectious Vaccines Market Data & Future Forecasts, By Product, 2016-2027 (USD Million)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Infectious Vaccines Market, by 2016-2027 (USD Million)
Fig.3 Infectious Vaccines Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Infectious Vaccines Market Driver Anlaysis
Fig.6 Infectious Vaccines Market Restraint Analysis
Fig.7 Infectious Vaccines Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Infectious Vaccines Market
Fig.10 Company Market Share Analysis, 2019

Infectious Vaccines Market Segmentation:

Infectious Vaccines Market, By Type (2016-2027)

  • Inactivated
  • Subunit
  • Conjugate
  • Attenuated
  • Others

Infectious Vaccines Market, By Product (2016-2027)

  • Therapeutic vaccine
  • Preventive vaccine
  • Others

Infectious Vaccines Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Infectious Vaccines Market:

  • Pfizer Inc.
  • Sanofi Pasteur
  • Merck and Company
  • Novartis AG
  • Johnson and Johnson
  • MedImmune LLC
  • Emergent Bio Solutions Inc.
  • GlaxoSmithKline plc.
  • CSL Limited
  • Bavarian Nordic

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.